Robert Gut
Vermögen: 2 Mio $ am 31.08.2026
Vermögen: 2 Mio $ am 31.08.2026
Robert Gut currently works at uniQure NV, as Independent Non-Executive Director from 2020.
Dr. Gut also formerly worked at Radius Health, Inc., as Vice President-Medical Affairs & Development, Novo Nordisk, Inc., as VP-Clinical Development & Medical Affairs, and Versartis, Inc., as Chief Medical Officer, Head-Clinical & Medical from 2017 to 2018.
Dr. Gut received his doctorate degree from Medical University of Lublin.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
UNIQURE N.V. 0.05% | 11.06.2026 | 32’259 ( 0.05% ) | 2 Mio $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| UNIQURE N.V. | Direktor/Vorstandsmitglied | 13.06.2018 |
| Unternehmen | Position | Ende |
|---|---|---|
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Technik-/Wissenschafts-/F&E-Leiter | 18.06.2018 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Technik-/Wissenschafts-/F&E-Leiter | - |
| RADIUS HEALTH, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Health Technology |
uniQure NV
uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products | Health Technology |
Medical University of Lublin
Medical University of Lublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen